Shiseido’s VOYAGER Platform Redefines Suncare with AI-Formulated Mist Launch
Published: 11 Mar 2026
Author: Precedence Research
In January 2026, Shiseido launched a mist-type suncare product using VOYAGER*, an AI-powered platform that leverages over 100 years of expertise and 500,000 formulation data points. Developed in partnership with Accenture, this platform, operational since 2024, is the first to integrate fragrance and color tone with SPF benefits in a product.
Shiseido's AI-Powered VOYAGER Accelerates Cosmetics Innovation
Under its open innovation program, fibona, Shiseido has upgraded its VOYAGER platform with an AI-powered function that generates and evaluates tens of thousands of potential formulations by digitizing complex, expert-level ingredient knowledge. This system enables faster development across various categories, allowing researchers to explore new perspectives and enabling junior staff to create high-quality, commercial-ready products.
According to Precedence Research, the BioSignal Serums Market size accounted for USD 6.25 billion in 2025 and is predicted to increase from USD 6.63 billion in 2026 to approximately USD 11.35 billion by 2035, expanding at a CAGR of 6.15% from 2026 to 2035 as demand grows for personalized, biomarker guided skin formulations that move beyond surface-level beauty into regenerative, evidence-based science.
This technology boosts research and development efficiency and fosters innovation, as demonstrated by the development of a lightweight, toner-like suncare product designed to make UV protection more enjoyable. The AI successfully identified consumer needs for effortless, high-performance, and sensory-focused products, leading to a new phase in Shiseido’s research and development.
Shiseido’s New Era of Personalization
The BioSignal Serums Market is experiencing a surge driven by AI-powered innovation, notably Shiseido's use of its VOYAGER platform to develop unique, high-performance suncare. By analyzing extensive data points for optimal, sensory-driven formulations, this technological shift mirrors the demand for precise, evidence-based, and personalized skincare solutions.
Going forward, Shiseido aims to push boundaries through AI collaboration, creating beauty solutions that meet diverse consumer needs and drive continuous innovation, aligning with its mission of BEAUTY INNOVATIONS FOR A BETTER WORLD.
A recent report by Precedence Research highlights that the BioSignal serums market is benefiting from rising demand for biomarker-guided, personalized skincare, specifically leveraging exosome and peptide technologies to trigger, rather than simply treat, skin repair.